[{"AccountsPayableCurrent_0_Q1_USD":3381000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":166001000.0,"OtherAssetsCurrent_0_Q1_USD":1879000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-19607000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":12.62,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-16000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":602000.0,"OtherNonoperatingIncome_1_Q1_USD":3165000.0,"InvestmentIncomeInterest_1_Q1_USD":280000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":258000.0,"DeferredTaxAssetsLiabilitiesNetNoncurrent_0_Q1_USD":111000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":177000.0,"DeferredRevenueCurrent_0_Q1_USD":1176000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":0.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":444275000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":36000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-916000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1048317.0,"OtherAssetsNoncurrent_0_Q1_USD":1275000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_1_Q1_USD":52000.0,"HeldToMaturitySecuritiesFairValue_0_Q1_USD":71465000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":13251000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-4602000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-3107000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":4841000.0,"OperatingLeasePayments_1_Q1_USD":393000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3484000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1393000.0,"OperatingLeaseCost_1_Q1_USD":396000.0,"LeaseCost_1_Q1_USD":478000.0,"InterestReceivableCurrent_0_Q1_USD":215000.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_1_Q1_USD":-3000.0,"HeldToMaturitySecurities_0_Q1_USD":71483000.0,"DeferredFederalIncomeTaxExpenseBenefit_1_Q1_USD":125000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-3002000.0,"DebtAndEquitySecuritiesUnrealizedGainLoss_1_Q1_USD":47000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-31812000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":214000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2291000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":2885000.0,"MarketableSecuritiesCurrent_0_Q1_USD":48234000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":1258000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1751000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2291000.0,"DeferredRevenueNoncurrent_0_Q1_USD":270000.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":-80000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":126000.0,"DueToRelatedPartiesNoncurrent_0_Q1_USD":84055000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":438000.0,"LiabilitiesCurrent_0_Q1_USD":35567000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":237962000.0,"Liabilities_0_Q1_USD":123376000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":4656000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-1092000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":386000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":97000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-16403000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-3988000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8882000.0,"DueToRelatedPartiesCurrent_0_Q1_USD":17458000.0,"CommonStockValue_0_Q1_USD":2931000.0,"CommonStockSharesOutstanding_0_Q1_shares":29009422.0,"CommonStockSharesIssued_0_Q1_shares":29009422.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":165800000.0,"AssetsCurrent_0_Q1_USD":225451000.0,"Assets_0_Q1_USD":237962000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-1521000.0,"AccountsReceivableNetCurrent_0_Q1_USD":244000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.68,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":17091000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-25260000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":148000.0,"CurrentStateAndLocalTaxExpenseBenefit_1_Q1_USD":-24000.0,"CurrentFederalTaxExpenseBenefit_1_Q1_USD":-56000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":66000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.015,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.939,"ShareBasedCompensation_1_Q1_USD":2291000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":16987000.0,"OperatingIncomeLoss_1_Q1_USD":-19568000.0,"OperatingExpenses_1_Q1_USD":25869000.0,"NetIncomeLoss_1_Q1_USD":-16500000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":2739000.0,"CommonStockParOrStatedValuePerShare_0_Q1_EUR":0.09,"AccruedLiabilitiesCurrent_0_Q1_USD":12159000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":28946000.0,"StockholdersEquity_0_Q1_USD":114586000.0,"Revenues_1_Q1_USD":6301000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-331099000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3545000.0,"ProfitLoss_1_Q1_USD":-16500000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":9915000.0,"CommonStockSharesAuthorized_0_Q1_shares":45000000.0,"VariableLeaseCost_1_Q1_USD":82000.0,"Ticker":"MRUS","CIK":"1651311","name":"MERUS N.V.","OfficialName":"Merus N.V. Common Shares","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1055622823.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]